Predictions
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€403.60
14.05.23
14.05.23
€700.00
14.05.24
14.05.24
76.01%
15.05.24
15.05.24
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
27.04.24
27.04.24
€200.00
27.04.25
27.04.25
5.58%
12.05.24
12.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
27.04.24
27.04.24
€200.00
27.04.25
27.04.25
5.58%
12.05.24
12.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
27.04.24
27.04.24
€200.00
27.04.25
27.04.25
5.58%
12.05.24
12.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€736.80
23.03.23
23.03.23
€791.57
23.03.24
23.03.24
20.86%
24.03.24
24.03.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€736.80
23.03.23
23.03.23
€791.57
23.03.24
23.03.24
20.86%
24.03.24
24.03.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€736.80
23.03.23
23.03.23
€791.57
23.03.24
23.03.24
20.86%
24.03.24
24.03.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€307.70
13.03.23
13.03.23
€350.10
13.03.24
13.03.24
124.73%
14.03.24
14.03.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€299.80
03.03.23
03.03.23
€339.30
03.03.24
03.03.24
142.83%
04.03.24
04.03.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€529.00
18.12.23
18.12.23
€558.00
18.12.24
18.12.24
6.62%
06.01.24
06.01.24
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market